Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug 2;7(1):262.
doi: 10.1038/s41392-022-01113-9.

Ketogenic diet: new avenues to overcome colorectal cancer

Affiliations
Comment

Ketogenic diet: new avenues to overcome colorectal cancer

Yuancai Xiang et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. Hongming Miao is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.

Figures

Fig. 1
Fig. 1
Schematic illustration of the molecular mechanisms underlying KD-mediated suppression in CRC growth. During a ketogenic diet, abundant ketone bodies, especially BHB, were produced in the liver and were transferred to colorectum via blood circulation. Once the concentration of BHB elevated around colorectal tumor cells, it binds to Hcar2, a G-protein-coupled receptors, and activation Hopx expression, thereby inhibiting cell proliferation and tumorigenesis through suppressing proliferative pathway, such as cell cycle. In addition, multiple combination treatment based on KD demonstrated additive effects on the suppression of CRC, such as the combination with glucose restriction, histone deacetylases inhibitors, and DNA methylation inhibitor. BHB: β-hydroxybutyrate; Hcar2: hydroxyl-carboxylic receptor 2; α, β, γ: G-protein subunits; Hopx: homeobox only protein homeobox; HDAC: histone deacetylases

Comment on

  • β-Hydroxybutyrate suppresses colorectal cancer.
    Dmitrieva-Posocco O, Wong AC, Lundgren P, Golos AM, Descamps HC, Dohnalová L, Cramer Z, Tian Y, Yueh B, Eskiocak O, Egervari G, Lan Y, Liu J, Fan J, Kim J, Madhu B, Schneider KM, Khoziainova S, Andreeva N, Wang Q, Li N, Furth EE, Bailis W, Kelsen JR, Hamilton KE, Kaestner KH, Berger SL, Epstein JA, Jain R, Li M, Beyaz S, Lengner CJ, Katona BW, Grivennikov SI, Thaiss CA, Levy M. Dmitrieva-Posocco O, et al. Nature. 2022 May;605(7908):160-165. doi: 10.1038/s41586-022-04649-6. Epub 2022 Apr 27. Nature. 2022. PMID: 35477756 Free PMC article.

References

    1. Dmitrieva-Posocco O, et al. β-Hydroxybutyrate suppresses colorectal cancer. Nature. 2022;605:160–165. doi: 10.1038/s41586-022-04649-6. - DOI - PMC - PubMed
    1. Grosso G, et al. Possible role of diet in cancer: systematic review andmultiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr. Rev. 2017;75:405–419. doi: 10.1093/nutrit/nux012. - DOI - PubMed
    1. Weng ML, et al. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Nat. Commun. 2020;11:1869. doi: 10.1038/s41467-020-15795-8. - DOI - PMC - PubMed
    1. Xiang W, et al. Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages. Signal. Transduct. Target. Ther. 2020;5:239. doi: 10.1038/s41392-020-00327-z. - DOI - PMC - PubMed
    1. Newman JC, Verdin E. β-Hydroxybutyrate: a signaling metabolite. Annu. Rev. Nutr. 2017;37:51–76. doi: 10.1146/annurev-nutr-071816-064916. - DOI - PMC - PubMed

Publication types